The GLP is committed to full transparency. Download and review our 2019 Annual Report

Roundup on trial: Glyphosate-cancer legal battle threatens US farm exports

| | September 26, 2019
rtr l h e
Image: Reuters/Jim Young
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Earlier [in September], a second Wyoming man filed a federal lawsuit against the agribusiness giant, Monsanto. It’s one of more than 18,000 lawsuits claiming the world’s most widely used pesticide causes cancer and that Monsanto has tried to cover up the risks. Reports that some agricultural experts in Montana are concerned that growing public scrutiny could affect trade and take away a tool for farmers. Others say they’re already losing that tool as weeds become more resistant.

Pesticide Education Specialist Cecil Tharp says whether or not something causes cancer, public opinion matters. Some of the European markets that import American grain are even more suspicious of glyphosate.

Related article:  In hyped claim organic milk is healthier, activist science meets bungled reporting

“There is increased scrutiny on glyphosate, now that’s a fact and it’s changing the markets somewhat where foreign markets now are testing for glyphosate residual at a much higher incidence,” Tharp says.

Glyphosate testing isn’t required in the U.S. unless the grains are organic or headed to a foreign market …. [T]here are international limits for glyphosate residues on food products, but some countries have started adopting their own standards. Last year, Italy cut back on imports of Canadian wheat because it had trace amounts of glyphosate.

Read full, original article: Public Scrutiny Of Roundup Affects International Grain Market

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend